Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses
  2. Normandin, Erica; Triana, Sergio; Raju, Siddharth S; Lan, Tammy C T; Lagerborg, Kim; Rudy, Melissa; Adams, Gordon C; DeRuff, Katherine C; Logue, James; Liu, David; Strebinger, Daniel; Rao, Arya; Messer, Katelyn S; Sacks, Molly; Adams, Ricky D; Janosko, Krisztina; Kotliar, Dylan; Shah, Rickey; Crozier,Ian; Rinn, John L; Melé, Marta; Honko, Anna N; Zhang, Feng; Babadi, Mehrtash; Luban, Jeremy; Bennett, Richard S; Shalek, Alex K; Barkas, Nikolaos; Lin, Aaron E; Hensley, Lisa E; Sabeti, Pardis C; Siddle, Katherine J
  3. Cell Genomics. 2023, Dec 13; 3(12): 100440.
  1. 2.   Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
  2. Warren,Travis; Kane,Christopher; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Steffens, Jesse; Gomba, Laura; Weidner, Jessica M.; Norris, Sarah; Zeng, Xiankun; Bannister, Roy; Cihlar, Tomas; Bavari, Sina; Porter, Danielle P.; Iversen, Patrick L.
  3. Scientific Reports. 2021, Sep 30; 11(1):
  1. 3.   Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture
  2. Shrivastava-Ranjan, Punya; Lo, Michael K.; Chatterjee, Payel; Flint, Mike; Nichol, Stuart T.; Montgomery, Joel M.; O'Keefe,Barry; Spiropoulou, Christina F.
  3. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2020, NOV 4; 10: 561502.
  1. 4.   Recent successes in therapeutics for Ebola virus disease: no time for complacency
  2. Iversen, Patrick L.; Kane, Christopher D.; Zeng, Xiankun; Panchal, Rekha G.; Warren, Travis K.; Radoshitzky, Sheli R.; Kuhn, Jens H.; Mudhasani, Rajini R.; Cooper, Christopher L.; Shurtleff, Amy C.; Nasar, Farooq; Sunay, Melek M. E.; Duplantier, Allen J.; Eaton, Brett P.; Zumbrun, Elizabeth E.; Bixler, Sandra L.; Martin, Shannon; Meinig, J. Matthew; Chiang, Chih-Yuan; Sanchez-Lockhart, Mariano; Palacios, Gustavo F.; Kugelman, Jeffrey R.; Martins, Karen A.; Pitt, Margaret L.; Crozier,Ian; Saunders, David L.
  3. The Lancet. Infectious diseases. 2020, SEP; 20(9): E231-E237.
  1. 5.   Filoviruses infect rhesus macaque synoviocytes in vivo and primary human synoviocytes in vitro
  2. Cooper, Timothy K; Logue, James; Liu, David X; Perry, Donna L; Hart, Randy J; Hischak, Amanda M W; Bernbaum, John G; Gerhardt, Dawn M; Rojas, Oscar; Bohannon, J Kyle; Hagen, Katie R; Johnson, Reed F; Crozier,Ian; Jahrling, Peter B; Hensley, Lisa E; Bennett, Richard S
  3. The American journal of pathology. 2020, SEP; 190(9): 1867-1880.
  1. 6.   A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967
  2. Ristanovic, Elizabeta S.; Kokoskov, Nenad S.; Crozier,Ian; Kuhn, Jens H.; Gligic, Ana S.
  3. Microbiology and molecular biology reviews : MMBR. 2020, Jun; 84(2):
  1. 7.   A systematic approach for studying the signs and symptoms of fever in adult patients: the fever assessment tool (FAST).
  2. Ames, Nancy J; Powers, John; Ranucci, Alexandra; Gartrell, Kyungsook; Yang, Li; VanRaden, Mark; Leidy, Nancy Kline; Wallen, Gwenyth R
  3. Health and quality of life outcomes. 2017, Apr 27; 15(1):
  1. 8.   The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation
  2. Ratner, Dmitry; Orning, M. Pontus A.; Proulx, Megan K.; Wang, Donghai; Gavrilin, Mikhail A.; Wewers, Mark D.; Alnemri, Emad S.; Johnson, Peter; Lee, Bettina; Mecsas, Joan; Kayagaki, Nobuhiko; Goguen, Jon D.; Lien, Egil
  3. PLOS PATHOGENS. 2016, Dec 2; 12(12): e1006035.
  1. 9.   Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: Clinical characterization and risk factors for severe disease
  2. Johnson, R. F.; Dodd, L. E.; Yellayi, S.; Gu, W. J.; Cann, J. A.; Jett, C.; Bernbaum, J. G.; Ragl, D. R.; St Claire, M.; Byrum, R.; Paragas, J.; Blaney, J. E.; Jahrling, P. B.
  3. Virology. 2011, Dec; 421(2): 129-140.
  1. 10.   Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1 beta Activation and Severe Autoinflammation in Mice
  2. Chae, J. J.; Cho, Y. H.; Lee, G. S.; Cheng, J.; Liu, P. P.; Feigenbaum, L.; Katz, S. I.; Kastner, D. L.
  3. Immunity. 2011, May; 34(5): 755-768.
  1. 11.   Multiplex cytokine analysis technologies
  2. Lash, G. E.; Pinto, L. A.
  3. Expert Review of Vaccines. 2010, Oct; 9(10): 1231-1237.
  1. 12.   Reduced Levels of Protein Tyrosine Phosphatase CD45 Protect Mice from the Lethal Effects of Ebola Virus Infection
  2. Panchal, R. G.; Bradfute, S. B.; Peyser, B. D.; Warfield, K. L.; Ruthel, G.; Lane, D.; Kenny, T. A.; Anderson, A. O.; Raschke, W. C.; Bavari, S.
  3. Cell Host & Microbe. 2009 6(2): 162-173.
  1. 13.   Human herpesvirus 8 seroprevalence among children and adolescents in the United States
  2. Anderson, L. A.; Li, Y.; Graubard, B. I.; Whitby, D.; Mbisa, G.; Tan, S.; Goedert, J. J.; Engels, E. A.
  3. Pediatric Infectious Disease Journal. 2008 27(7): 661-664.
  1. 14.   IL-10 helps control pathogen load during high-level bacteremia
  2. Londono, D.; Marques, A.; Hornung, R. L.; Cadavid, D.
  3. Journal of Immunology. 2008 181(3): 2076-2083.
  1. 15.   Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent
  2. Warfield, K. L.; Swenson, D. L.; Olinger, G. G.; Kalina, W. V.; Viard, M.; Aitichou, M.; Chi, X.; Ibrahim, S.; Blumenthal, R.; Raviv, Y.; Bavari, S.; Aman, M. J.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S276-S283.
  1. 16.   Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus
  2. Larsen, T.; Stevens, E. L.; Davis, K. J.; Geisbert, J. B.; Daddario-DiCaprio, K. M.; Jahrling, P. B.; Hensley, L. E.; Geisbert, T. W.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S323-S328.
  1. 17.   In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein
  2. Ebihara, H.; Theriault, S.; Neumann, G.; Alimonti, J. B.; Geisbert, J. B.; Hensley, L. E.; Groseth, A.; Jones, S. M.; Geisbert, T. W.; Kawaoka, Y.; Feldmann, H.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S313-S322.
  1. 18.   Lymphocyte death in a mouse model of Ebola virus infection
  2. Bradfute, S. B.; Braun, D. R.; Shamblin, J. D.; Geisbert, J. B.; Paragas, J.; Garrison, A.; Hensley, L. E.; Geisbert, T. W.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S296-S304.
  1. 19.   Marburg virus Angola infection of rhesus macaques: Pathogenesis and treatment with recombinant nematode anticoagulant protein c2
  2. Geisbert, T. W.; Daddario-DiCaprio, K. M.; Geisbert, J. B.; Young, H. A.; Formenty, P.; Fritz, E. A.; Larsen, T.; Hensley, L. E.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S372-S381.
  1. 20.   High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatoe
  2. Gelderblom, H.; Londono, D.; Bai, Y. H.; Cabral, E. S.; Quandt, J.; Hornung, R.; Martin, R.; Marques, A.; Cadavid, D.
  3. Journal of Neuropathology and Experimental Neurology. 2007, Mar; 66(3): 208-217.
  1. 21.   Panmicrobial oligonucleotide array for diagnosis of infectious diseases
  2. Palacios, G.; Quan, P. L.; Jabado, O. J.; Conlan, S.; Hirschberg, D. L.; Liu, Y.; Zhai, J.; Renwick, N.; Hui, J.; Hegyi, H.; Grolla, A.; Strong, J. E.; Towner, J. S.; Geisbert, T. W.; Jahrling, P. B.; Buechen-Osmond, C.; Ellerbrok, H.; Sanchez-Seco, M. P.; Lussier, Y.; Formenty, P.; Nichol, S. T.; Feldmann, H.; Briese, T.; Lipkin, W. I.
  3. Emerging Infectious Diseases. 2007, Jan; 13(1): 73-81.
  1. 22.   Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by Marburg and Ebola viruses
  2. Mohamadzadeh, M.; Coberley, S. S.; Olinger, G. G.; Kalina, W. V.; Ruthel, G.; Fuller, C. L.; Swenson, D. L.; Pratt, W. D.; Kuhns, D. B.; Schmaljohn, A. L.
  3. Journal of Virology. 2006, Jul; 80(14): 7235-7244.
  1. 23.   Structure and age of genetic diversity of dengue virus type 2 in Thailand
  2. Zhang, C. L.; Marnmen, M. P.; Chinnawirotpisan, P.; Klungthong, C.; Rodpradit, P.; Nisalak, A.; Vaughn, D. W.; Nimmannitya, S.; Kalayanarooj, S.; Holmes, E. C.
  3. Journal of General Virology. 2006, Apr; 87: 873-883.
  1. 24.   Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses
  2. Bolken, T. C.; Laquerre, S.; Zhang, Y. M.; Bailey, T. R.; Pevear, D. C.; Kickner, S. S.; Sperzel, L. E.; Jones, K. F.; Warren, T. K.; Lund, S. A.; Kirkwood-Watts, D. L.; King, D. S.; Shurtleff, A. C.; Guttieri, M. C.; Deng, Y. J.; Bleam, M.; Hruby, D. E.
  3. Antiviral Research. 2006, Feb; 69(2): 86-97.
  1. 25.   Rapid identification of dengue virus by reverse transcription-polymerase chain reaction using field-deployable instrumentation
  2. McAvin, J. C.; Escamilla, E. M.; Blow, J. A.; Turell, M. J.; Quintana, M.; Bowles, D. E.; Swaby, J. A.; Barnes, W. J.; Huff, W. B.; Lohman, K. L.; Atchley, D. H.; Hickman, J. R.; Niemeyer, D. M.
  3. Military Medicine. 2005, Dec; 170(12): 1053-1059.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel